Ramsell Corporation CEO Eric Flowers Joins Sutter Health East Bay Board of Directors

Oakland, Calif. – February 11, 2014 – Ramsell today announced that Eric Flowers, chief executive officer of Ramsell, was elected to Sutter Health East Bay’s board of directors. Sutter Health East Bay includes: Alta Bates Summit Medical Center, Eden Medical Center, Sutter Delta Medical Center, and Sutter East Bay Medical Foundation. Eric also sits on the Advisory Board of Saint Mary’s College School of Economics and Business Administration and the ADAP Advocacy Association (aaa+), a non-profit that promotes and enhances AIDS Drug Assistance Programs (ADAPs) and improves access to care for people living with HIV/AIDS. 

Are HRSA 340B Audits Keeping You Up At Night?

HRSA’s budget was recently increased from $4.4 million to $10.2 million. The increase in funding is expected to enable HRSA to implement 340B program integrity compliance initiatives.

HRSA plans to conduct risk based and targeted audits of 340B covered entities. Using an audit protocol specific to the 340B Program, the HRSA risk based and targeted audits will involve an in depth review and focused audit of covered entities’ 340B Program operations and compliance.

50th Anniversary of The Apothecary Pharmacy in Oakland, California

Yesterday, January 6, 2014, marked the 50th Anniversary of The Apothecary Pharmacy – which inspired Ramsell’s mission of serving the underserved.

On January 6, 1964, our founder, Sylester Flowers, started the first African-American owned community pharmacy in East Oakland, Calif. during a period when other pharmacies – independent or chain were fearful of venturing into the underserved communities. Syl eventually owned six community-based pharmacies across the Bay Area. 

Alameda County to Include Ramsell's PBM for Behavioral Health Program

Ramsell, a leading provider of innovative solutions for organizations that serve the underserved, today announced a new partnership with Alameda County Behavioral Health Care Services to provide pharmacy benefits management... Read more >>

340B Coalition Annual Conference

The 340B conference held July 7-9, 2013 brought over a thousand attendees in what was considered, another successful and informative event.  The HRSA recertification deadline and the Orphan Drug exclusion were the hot topics from the event.

The popularity of the 340B program further prompted discussions around audit and compliance and scrutiny from Congress and HRSA  for program accountability. HRSA continues its plans to audit Covered Entities, with at least 30 audits completed so far this year, with many more expected before the end of the year.

Benefits of 340B Drug Program

The 340B program's merit has consistently been scrutinized.  Recent news suggests the 340B program is indeed beneficial to the healthcare society.  Twenty-nine members of the senate are advocates of the program.  Members of the house champion the 340B program and have concluded that the results indicate reduced pharmaceutical costs, to serve low-income patients and other vulnerable patients.